EPA guidance on assessment of negative symptoms in schizophrenia S Galderisi, A Mucci, S Dollfus, M Nordentoft, P Falkai, S Kaiser, ... European Psychiatry 64 (1), e23, 2021 | 158 | 2021 |
EPA guidance on treatment of negative symptoms in schizophrenia S Galderisi, S Kaiser, I Bitter, M Nordentoft, A Mucci, M Sabé, ... European Psychiatry 64 (1), e21, 2021 | 103 | 2021 |
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends M Sabe, T Pillinger, S Kaiser, C Chen, H Taipale, A Tanskanen, ... Neuroscience & Biobehavioral Reviews 136, 104608, 2022 | 87 | 2022 |
Physical exercise for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis M Sabe, S Kaiser, O Sentissi General hospital psychiatry 62, 13-20, 2020 | 82 | 2020 |
Meditation-based mind-body therapies for negative symptoms of schizophrenia: systematic review of randomized controlled trials and meta-analysis M Sabe, O Sentissi, S Kaiser Schizophrenia research 212, 15-25, 2019 | 59 | 2019 |
Half a century of research on attention-deficit/hyperactivity disorder: A scientometric study S Cortese, M Sabé, C Chen, N Perroud, M Solmi Neuroscience & Biobehavioral Reviews 140, 104769, 2022 | 42 | 2022 |
Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials M Sabe, N Zhao, A Crippa, S Kaiser NPJ schizophrenia 7 (1), 43, 2021 | 38 | 2021 |
Thirty years of research on negative symptoms of schizophrenia: A scientometric analysis of hotspots, bursts, and research trends M Sabe, C Chen, N Perez, M Solmi, A Mucci, S Galderisi, GP Strauss, ... Neuroscience & Biobehavioral Reviews 144, 104979, 2023 | 30 | 2023 |
Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studies M Sabe, N Zhao, S Kaiser Neuroscience & Biobehavioral Reviews 116, 415-425, 2020 | 30 | 2020 |
Prodopaminergic drugs for treating the negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials M Sabe, M Kirschner, S Kaiser Journal of clinical psychopharmacology 39 (6), 658-664, 2019 | 28 | 2019 |
Thirty years of research on physical activity, mental health, and wellbeing: A scientometric analysis of hotspots and trends M Sabe, C Chen, O Sentissi, J Deenik, D Vancampfort, J Firth, L Smith, ... Frontiers in public health 10, 943435, 2022 | 24 | 2022 |
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies N Perez, F Langlest, L Mallet, M De Pieri, O Sentissi, G Thorens, ... European Neuropsychopharmacology 76, 61-76, 2023 | 20 | 2023 |
Intranasal oxytocin for negative symptoms of schizophrenia: systematic review, meta-analysis, and dose-response meta-analysis of randomized controlled trials M Sabe, N Zhao, A Crippa, GP Strauss, S Kaiser International Journal of Neuropsychopharmacology 24 (8), 601-614, 2021 | 20 | 2021 |
Comparative effects of 11 antipsychotics on weight gain and metabolic function in patients with acute schizophrenia: a dose-response meta-analysis M Sabé, K Pallis, M Solmi, A Crippa, O Sentissi, S Kaiser The Journal of Clinical Psychiatry 84 (2), 45463, 2023 | 19 | 2023 |
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs M Solmi, C Chen, C Daure, A Buot, M Ljuslin, V Verroust, L Mallet, ... European Neuropsychopharmacology 64, 44-60, 2022 | 19 | 2022 |
Toxicity of psychotropic drugs in patients with COVID-19: a systematic review M Sabe, O Dorsaz, P Huguelet, S Kaiser General hospital psychiatry 70, 1-9, 2021 | 19 | 2021 |
Zolpidem stimulant effect: induced mania case report and systematic review of cases M Sabe, H Kashef, C Gironi, O Sentissi Progress in Neuro-Psychopharmacology and Biological Psychiatry 94, 109643, 2019 | 19 | 2019 |
A systematic review and meta-analysis of the prevalence of cocaine-induced psychosis in cocaine users M Sabe, N Zhao, S Kaiser Progress in Neuro-Psychopharmacology and Biological Psychiatry 109, 110263, 2021 | 15 | 2021 |
A century of research on neuromodulation interventions: a scientometric analysis of trends and knowledge maps M Sabé, A Sulstarova, C Chen, J Hyde, E Poulet, A Aleman, J Downar, ... Neuroscience & Biobehavioral Reviews, 105300, 2023 | 10 | 2023 |
Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series M Sabe, O Sentissi International Journal of Psychiatry in Clinical Practice 26 (3), 287-293, 2022 | 10 | 2022 |